Functional domains of CCN1 (Cyr61) regulate breast cancer progression

International Journal of Oncology

Volumn 33, Issue 1, 2008, Pages 59-67

  O'Kelly, James ^a,b   Chung, Alice ^a   Lemp, Nathan ^a   Chumakova, Katya ^a   Yin, Dong ^a   Wang, He Jing ^a   Said, Jonathan ^a   Gui, Dorina ^a   Miller, Carl W ^a   Karlan, Beth Y ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Global Medical Writing   (United States)

Author keywords

Breast cancer; Cyr61; Extracellular matrix

Indexed keywords

CYSTEINE RICH PROTEIN 61; HEPARIN; MUTANT PROTEIN; CYR61 PROTEIN, HUMAN; ESTROGEN RECEPTOR; IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SIGNAL PEPTIDE;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; LYMPH NODE METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION; BREAST TUMOR; CHEMISTRY; DISEASE COURSE; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN;

EID: 51049112312     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.33.1.59     Document Type: Article

References (40)

1. Brigstock DR: The connective tissue growth factor/cysteine rich/ nephroblastoma overexpressed (CCN) family. Endocr Rev 20: 189-206, 1999.
2. Grotendorst GR, Lau LF and Perbal B: CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology 141: 2254-2256, 2000.
3. Babic AM, Kireeva ML, Kolesnikova TV and Lau LF: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95: 6355-6360, 1998.
4. Kireeva ML, Mo FE, Yang GP and Lau LF: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration and adhesion. Mol Cell Biol 16: 1326-1334, 1996.
5. O'Kelly J and Koeffler HP: The role of CCN1 in tumorigenesis and cancer progression. In: CCN proteins. Perbal B (ed). Imperial College Press, 2005.
6. Xie D, Miller CW, O'Kelly J, et al: Breast cancer: Cyr61 is overexpressed, estrogen inducible and associated with more advanced disease. J Biol Chem 276: 14187-14194, 2001.
7. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C and Koeffler HP: Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 276: 47709-47714, 2001.
8. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 363: 62-64, 2004.
9. Pendurthi UR, Tran TT, Post M and Rao LV: Proteolysis of CCN1 by plasmin: functional implications. Cancer Res 65: 9705-9711, 2005.
10. Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130, 1993.
11. Chen N, Leu SJ, Todorovic V, Lam SC and Lau LF: Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 279: 44166-44176, 2004.
12. Leu SJ, Chen N, Chen CC, et al: Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions. J Biol Chem 279: 44177-44187, 2004.
13. Schober JM, Lau LF, Ugarova TP and Lam SC: Identification of a novel integrin αMβ2 Binding Site in CCN1(CYR61), a matr-cellular protein expressed in healing wounds and atherosclerotic lesions. J Biol Chem 278: 25808-25815, 2003.
14. Chen N, Chen CC and Lau LF: Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparan sulfate proteoglycans. J Biol Chem 275: 24953-24961, 2000.
15. Taddei I, Faraldo MM, Teuliere J, Deugnier MA, Thiery JP and Glukhova MA: Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia 8: 383-394, 2003.
16. Felding-Habermann B, O'Toole TE, Smith JW, et al: Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001.
17. Wu C and Dedhar S: Integrin-linked linase and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505-510, 2001.
18. Vellon L, Menendez JA and Lupu R: AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene 24: 3759-3773, 2005.
19. Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW and Lupu R: A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ ERK2 MAPK signaling pathway. Oncogene 24: 761-779, 2005.
20. Tsai MS, Hornby AE, Lakins J and Lupu R: Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res 60: 5603-5607, 2000.
21. Sampath D, Winneker RC and Zhang Z: Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer. Endocrinology 142: 2540-2548, 2001.
22. Xie D, Nakachi K, Wang H, Elashoff R and Koeffler HP: Elevated levels of connective tissue growth factor, WISP-1 and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61: 8917-8923, 2001.
23. Tsai MS, Bogart DF, Castaneda JM, Li P and Lupu R: Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21: 8178-8185, 2002.
24. Sampath D, Zhu Y, Winneker RC and Zhang Z: Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab 86: 1707-1715, 2001.
25. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K and Mansel RE: Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11: 781-791, 2004.
26. Grotendorst GR and Duncan MR: Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19: 729-738, 2005.
27. Planque N, Long Li C, Saule S, Bleau AM and Perbal B: Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 99: 105-116, 2006.
28. Lau LF and Lam SC-T: The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248: 44-57, 1999.
29. Roskelley CD and Bissell MJ: The dominance of the micro-environment in breast and ovarian cancer. Semin Cancer Biol 12: 97-110, 2002.
30. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
31. Chen CC, Mo FE and Lau LF: The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276: 47329-47337, 2001.
32. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF and Lam SC: Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/ mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 274: 24321-24327, 1999.
33. Grzeszkiewicz TM, Kirschling DJ, Chen N and Lau LF: CYR61 stimulates human skin fibroblast migration through Integrin alpha v beta 5 and enhances mitogenesis through integrin alpha v beta 3, independent of its carboxyl-terminal domain. J Biol Chem 276: 21943-21950, 2001.
34. Liapis H, Flath A and Kitazawa S: Integrin alpha V beta 3 expression by bone-residing breast cancer metastases. Diagn Mol Pathol 5: 127-135, 1996.
35. Pecheur I, Peyruchaud O, Serre CM, et al: Integrin alpha(v) beta3 expression confers on tumor cells a greater propensity to metastasize to. bone. FASEB J 16: 1266-1238, 2002.
36. White DE, Cardiff RD, Dedhar S and Muller WJ: Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20: 7064-7072, 2001.
37. Kunz M, Moeller S, Koczan D, et al: Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 278: 45651-45660, 2003.
38. Bartholin L, Wessner LL, Chirgwin JM and Guise TA: The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett 246: 230-236, 2007.
39. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR and Harding PA: Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272: 20275-20282, 1997.
40. Chien W, Kumagai T, Miller CW, et al: Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279: 53087-53096, 2004.